Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX

NCT05372562 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05372562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05372562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX
Lead sponsor
Peking University
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
April 30, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema